Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease.

Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ.

Front Neurol. 2015 Nov 12;6:237. doi: 10.3389/fneur.2015.00237. eCollection 2015.

2.

Sickle Cell Trait from a Metabolic, Renal, and Vascular Perspective: Linking History, Knowledge, and Health.

Thoreson CK, O'Connor MY, Ricks M, Chung ST, Sumner AE.

J Racial Ethn Health Disparities. 2015 Sep;2(3):330-5. doi: 10.1007/s40615-014-0077-4. Review.

3.

Genetics and Personal Insurance: the Perspectives of Canadian Cancer Genetic Counselors.

Lane M, Ngueng Feze I, Joly Y.

J Genet Couns. 2015 Dec;24(6):1022-36. doi: 10.1007/s10897-015-9841-9. Epub 2015 May 1.

4.

Bioethical issues of preventing hereditary diseases with late onset in the Sakha Republic (Yakutia).

Kononova SK, Sidorova OG, Fedorova SA, Platonov FA, Izhevskaya VL, Khusnutdinova EK.

Int J Circumpolar Health. 2014 Jul 24;73:25062. doi: 10.3402/ijch.v73.25062. eCollection 2014.

6.

What Factors Impact upon a Woman's Decision to Undertake Genetic Cancer Testing?

Quinlivan JA, Battikhi Z, Petersen RW.

Front Oncol. 2014 Jan 6;3:325. doi: 10.3389/fonc.2013.00325. eCollection 2014 Jan 6.

7.

Using genetically informed, randomized prevention trials to test etiological hypotheses about child and adolescent drug use and psychopathology.

Brody GH, Beach SR, Hill KG, Howe GW, Prado G, Fullerton SM.

Am J Public Health. 2013 Oct;103 Suppl 1:S19-24. doi: 10.2105/AJPH.2012.301080. Epub 2013 Aug 8.

8.

Genetic discrimination and life insurance: a systematic review of the evidence.

Joly Y, Ngueng Feze I, Simard J.

BMC Med. 2013 Jan 31;11:25. doi: 10.1186/1741-7015-11-25. Review.

9.

Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study.

Goh AM, Chiu E, Yastrubetskaya O, Erwin C, Williams JK, Juhl AR, Paulsen JS; I-Respond-Hd Investigators Of The Huntington Study Group.

Genet Test Mol Biomarkers. 2013 Feb;17(2):115-21. doi: 10.1089/gtmb.2012.0288. Epub 2013 Jan 4.

10.

Personalized medicine and access to health care: potential for inequitable access?

McClellan KA, Avard D, Simard J, Knoppers BM.

Eur J Hum Genet. 2013 Feb;21(2):143-7. doi: 10.1038/ejhg.2012.149. Epub 2012 Jul 11.

11.

Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.

Geelen E, Horstman K, Marcelis CL, Doevendans PA, Van Hoyweghen I.

Eur J Hum Genet. 2012 Oct;20(10):1018-23. doi: 10.1038/ejhg.2012.53. Epub 2012 Mar 28.

12.

Genetic screening: The vista of genomic medicine.

Saini R, Saini S, Saini G.

J Pharm Bioallied Sci. 2011 Jan;3(1):109-12. doi: 10.4103/0975-7406.76487.

13.

Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Bombard Y, Palin J, Friedman JM, Veenstra G, Creighton S, Paulsen JS, Bottorff JL, Hayden MR; Canadian Respond-HD Collaborative Research Group.

Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):19-27. doi: 10.1002/ajmg.b.31130. Epub 2010 Nov 10.

14.

Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.

Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS; I-RESPOND-HD Investigators of the Huntington Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jul;153B(5):1081-93. doi: 10.1002/ajmg.b.31079.

15.

Myriad Genetics: In the eye of the policy storm.

Gold ER, Carbone J.

Genet Med. 2010 Apr;12(4 Suppl):S39-70. doi: 10.1097/GIM.0b013e3181d72661.

16.

Views of discrimination among individuals confronting genetic disease.

Klitzman R.

J Genet Couns. 2010 Feb;19(1):68-83. doi: 10.1007/s10897-009-9262-8.

17.

Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.

Bombard Y, Veenstra G, Friedman JM, Creighton S, Currie L, Paulsen JS, Bottorff JL, Hayden MR; Canadian Respond-HD Collaborative Research Group.

BMJ. 2009 Jun 9;338:b2175. doi: 10.1136/bmj.b2175.

18.

Two cheers for GINA?

McGuire AL, Majumder MA.

Genome Med. 2009 Jan 20;1(1):6. doi: 10.1186/gm6.

19.

Legal update: living with the Genetic Information Nondiscrimination Act.

Erwin C.

Genet Med. 2008 Dec;10(12):869-73. doi: 10.1097/GIM.0b013e31818ca4e7.

20.

Civilian and military genetics: nondiscrimination policy in a post-GINA world.

Baruch S, Hudson K.

Am J Hum Genet. 2008 Oct;83(4):435-44. doi: 10.1016/j.ajhg.2008.09.003.

Supplemental Content

Support Center